(Press-News.org) A drug that has been on the market for decades to treat leukemia and skin disorders such as acne and psoriasis may be a possible therapy for vascular diseases, including atherosclerosis and hypertension, which can lead to heart attack or stroke.
Previously, researchers discovered that retinoids – commonly used natural or man-made drugs related to vitamin A – blunted experimental vascular disease by spurring into action a very particular segment of a gene known for its ability to curb cancer cell growth.
The gene, usually shut off or silenced in cancer cells, enabling tumors to form, could be an attractive treatment target not only for vascular diseases, which involve the detrimental growth, spread and accumulation of cells in blood vessels, but for a wide range of cancers, which involve unchecked cell growth, as well.
In the journal PLoS One, a team of researchers led by Joseph M. Miano, Ph.D., associate director of the Aab Cardiovascular Research Institute at the University of Rochester Medical Center, found that a specific section of the complex AKAP12 gene, called AKAP12 beta, is extremely responsive to treatment with retinoids, and that ramping up its activity reduces vascular cell growth.
"Several studies have shown that when this gene is turned on, it decreases the growth of cancer cells, but this is the first time anyone's shown its ability to inhibit growth in non-cancer cells," said Miano, the study's lead author. "In addition to the vascular angle, we hope this work inspires researchers in different disciplines to see if our findings apply in other disease contexts."
A vascular biologist, Miano became interested in retinoids after people close to him battled cancer. When he learned that retinoids, which have several actions, including regulating cell growth, were a treatment option for some cancer patients, he wondered if they might have any use in treating diseases of blood vessels. Like cancer, vascular diseases such as atherosclerosis – the narrowing of the arteries – involve excessive cell growth and invasion. Such activities can lead to blocked arteries that obstruct blood flow.
Miano decided to give the idea a try, and in the late 1990's he showed in tissue and in an animal model of vascular disease that retinoids inhibited the growth of smooth muscle cells, which are found within the walls of vessels and contribute to atherosclerosis, which can lead to heart attack or stroke.
In the early 2000's, his team identified a number of genes that were activated or turned on by retinoids, one of which was AKAP12. Because research in the cancer field suggested it was a tumor suppressor gene, named for its ability to hinder cancer cell growth, Miano honed in on AKAP12 to see if it might be a target of retinoids in the context of vascular disease.
The team discovered that AKAP12 is a very complex gene, with three distinct DNA segments, named AKAP12 alpha, beta and gamma. Miano noted, "It is essentially like having three genes in one." Gene expression analyses revealed that the treatment of damaged vessels with retinoids immediately stimulated AKAP12 beta into action, while the alpha and gamma segments showed no response to the therapy.
"There are lots of tumor suppressor genes out there, and a few are mildly responsive to retinoids, but this is the first time we've seen a gene – AKAP12 beta – respond so early and so profoundly to retinoid stimulation," said Miano. "Without AKAP12 beta up and running, it is as if there are no brakes and the smooth muscle cells are free to grow. But when AKAP12 beta is amplified, the opposite is true, and we see major decreases in smooth muscle cell growth."
Once AKAP12 beta is switched into "go" mode by retinoids, the team believes it helps deter cell growth by reigning in and directing the action of specific signaling proteins that influence cell growth and migration. More research is needed to pin down the exact processes involved, and Miano hopes to pursue this work in the future by exploring animal models in which AKAP12 is eliminated or turned on with drugs.
According to Irwin H. Gelman, Ph.D., who was the first to identify the AKAP12 gene and has been studying its role in cancer for many years, "This study makes sense and is very consistent with what we've found in cancer cells, which is that AKAP12 is a prime driver to stop the proliferation of cells." Gelman, a study author who has worked with Miano for more than ten years, is the Palisano Chair of Cancer Genetics at Roswell Park Cancer Institute in Buffalo, New York.
"It may be possible that other diseases marked by inappropriate cell proliferation due to AKAP12 turn-off could also be reversed by retinoid treatment," added Gelman.
###
In addition to Miano, Jeffrey W. Streb, Xiaochun Long, Ting-Hein Lee, Qiang Sun, Chad M. Kitchen, Mary A. Georger, and Orazio J. Slivano from the Aab Cardiovascular Research Institute contributed to the research. Gelman, William S. Blaner, Columbia University, and Daniel W. Carr, Portland Veterans Affairs Medical Center participated in the research as well. The study was funded by the National Heart, Lung and Blood Institute at the National Institutes of Health and the Department of Veterans Affairs at the Veterans Health Administration.
Multitasking meds: Scientists discover how drug for leukemia, psoriasis, may tackle vascular disease
2011-05-27
ELSE PRESS RELEASES FROM THIS DATE:
July 2011 Geology highlights -- articles posted ahead of print May 24
2011-05-27
Boulder, CO, USA - Locations studied include Alligator Point, Cat Island, Bahamas; Rice Lake, Ontario, Canada; Liverpool Land, east Greenland; Mount Rainier, Washington, USA; the Yangtze Gorges area, South China; the Moresby Seamount detachment, Woodlark Basin (east of Papua New Guinea); Hilo Ridge, Hawaii, USA; the Isua supracrustal belt, southern West Greenland; the northern Bohemian Massif; the Lonar crater, Deccan traps, India; the Rhone Glacier; and the Mersa/Wadi Gawasis along the Egyptian Red Sea coast.
Keywords: Jurassic Tank, Cat Island, sediment transfer, ground-based ...
Bob Jones, General Manager of Augustine Casino, Reveals the Secrets to Becoming a Hot Spot for Locals with Business Review USA
2011-05-27
In an interview with Business Review USA, Bob Jones, General Manager of Augustine Casino discusses how the facility has grown in its community and integrated green initiatives with exceptional service.
Augustine Casino is truly "a locals' casino" and prides itself on the tremendous job it has done to grow over the years. "We've really made a focused effort to ensure that when a guest comes to our property that they can have great food at a reasonable price, slot machines with the loosest pay tables in the area, table games with fair, player-friendly rules ...
Study finds 2 gene classes linked to new prion formation
2011-05-27
Unlocking the mechanisms that cause neurodegenerative prion diseases may require a genetic key, suggest new findings reported by University of Illinois at Chicago distinguished professor of biological sciences Susan Liebman.
Prions can turn a normal protein into a misfolded form. One prion in mammals promotes progressive neurodegenerative disorders like "mad cow" disease that often prove fatal. But how this process happens remains an open question for scientists.
Prions have been found to exist in a wide range of organisms. Those in brewer's yeast, which researchers ...
Iowa State physicists explain the long, useful lifetime of carbon-14
2011-05-27
AMES, Iowa – The long, slow decay of carbon-14 allows archaeologists to accurately date the relics of history back to 60,000 years.
And while the carbon dating technique is well known and understood (the ratio of carbon-14 to other carbon isotopes is measured to determine the age of objects containing the remnants of any living thing), the reason for carbon-14's slow decay has not been understood. Why, exactly, does carbon-14 have a half-life of nearly 6,000 years while other light atomic nuclei have half-lives of minutes or seconds? (Half-life is the time it takes for ...
Students who struggle with math may have a neurocognitive disorder called dyscalculia
2011-05-27
Students who struggle to learn mathematics may have a neurocognitive disorder that inhibits the acquisition of basic numerical and arithmetic concepts, according to a new paper by University of Minnesota and British researchers. Called developmental dyscalculia, the disorder affects roughly the same number of people as dyslexia but has received much less attention (and research funding). The paper by University of Minnesota Educational Psychology assistant professor Sashank Varma and his British colleagues that shines a light on the causes of and interventions for dyscalculia ...
Study shows brain's response to sadness can predict relapses into depression
2011-05-27
A University of Toronto study shows that when formerly depressed people experience mild states of sadness, their brain's response can predict if they will become depressed again.
"Part of what makes depression such a devastating disease is the high rate of relapse," says Norman Farb, a PhD psychology student and lead author of the study. "However, the fact that some patients are able to fully maintain their recovery suggests the possibility that different responses to the type of emotional challenges encountered in everyday life could reduce the chance of relapse."
Farb ...
Get Your Solar Inverter 'Fix' from Fronius Australia with Business Review Australia
2011-05-27
Business Review Australia takes a look at Fronius Australia. Austrian-based Fronius International has been developing and manufacturing welding equipment and battery technology for over half a century. Since 1995, Fronius expanded its operations to include solar power electronics. With operations spanning the globe, Fronius inverters have been available to the Australian market since 1992. Fronius International realized the growing potential of the Australian solar power market and opened a solar electronics division in Melbourne in October 2010.
Fronius Australia now ...
Aging, obsolete cells prime the lungs for pneumonia
2011-05-27
SAN ANTONIO (May 26, 2011) — Community-acquired pneumonia is the leading cause of infectious death among the elderly. Newly published research from The University of Texas Health Science Center San Antonio suggests why older people are vulnerable and offers a possible defense.
The researchers found that when it comes to aging and pneumonia, one bad apple can ruin the barrel. Lung cells that were supposed to die due to DNA damage — but didn't — were 5 to 15 times more susceptible to invasion by pneumonia-causing bacteria. These bad apples also increased the susceptibility ...
TGen study identifies compounds that could slow down Alzheimer's disease
2011-05-27
PHOENIX, Ariz. — May 26, 2011 — A family of naturally occurring plant compounds could help prevent or delay memory loss associated with Alzheimer's disease, according to a new study by the Translational Genomics Research Institute (TGen).
Beta-carboline alkaloids could potentially be used in therapeutic drugs to stop, or at least slow down, the progressively debilitating effects of Alzheimer's, according to the study published recently in the scientific journal Public Library of Science (PLoS) One.
One of these alkaloids, called harmine, inhibits a protein known as ...
Common transplant drug inhibits breast cancer growth, UNC laboratory study shows
2011-05-27
Tacrolimus, a drug that is commonly used to prevent organ transplantation rejection, inhibits breast cancer growth in pre-clinical studies. The finding from UNC scientists was reported in the May 26th PLoS ONE.
Nancy Klauber-DeMore, MD, associate professor of surgery, said, " We now have a rationale for performing human clinical trials to determine if Tacrolimus reduces breast cancer growth in humans. Since Tacrolimus is already an FDA-approved drug, the safety and toxicity profile is known, which means that Tacrolimus could potentially go directly into a later stage ...